Top 10 Life Science Startup Investors in Austria (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
xista science ventures
VC Fund
|
3 | Austria | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | |
|
Longevitytech.fund
VC Fund
|
2 | United States, United Kingdom, The Netherlands | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Personal Health | $255k–$3.2M |
|
APEX Ventures
VC Fund
|
2 | Germany, Austria, United Kingdom | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $643k–$16M |
|
R42 Group
VC Fund
|
2 | United Kingdom, United States, Austria | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Information Technology | $429k–$15M |
|
Nina Capital
VC Fund
|
2 | United States, United Kingdom, Austria | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Medical | $573k–$21M |
|
tecnet equity
VC Fund
|
1 | Austria | Seed, Series A | Software, SaaS, Information Technology | $214k–$5.9M |
|
FastVentures
VC Fund
|
1 | Hungary, South Korea, United States | Seed, Series A, Series B | Software, Biotechnology, Information Technology | |
|
OrbiMed
VC Fund
|
1 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $10M–$120M |
|
HCVC
VC Fund
|
1 | United States, France, United Kingdom | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Manufacturing | $250k–$31M |
|
Polaris Partners
VC Fund
|
1 | United States, Singapore, Ireland | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $3.5M–$117M |
| Access all 27 investors in Austria Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 19
- Lead/follow: 70% lead, 30% follow
Portfolio highlights
- Prewave — Supplier monitoring for purchasing, supply chain management and sustainability managers.
- subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
- ReCatalyst — REvolutionizing the way we make fuel cell CATALYSTs
Investing globally in technologies extending healthy lifespans
Show more...Investment focus
- Industry: Biotechnology, Health Care, Personal Health
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 45
- Round size: Seed $255k–$3.2M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
- Cosmica Biosciences — Cosmica.bio - Rewiring molecular resilience for longevity & space exploration
- Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.
APX Ventures offers digital solutions, including pay-per-click, custom web services, SEO, and cloud services.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Austria, United Kingdom
Investor stats
- Total investments: 40
- Round size: Seed $643k–$5.9M; Pre-Seed $643k–$1.7M; Series A $6M–$16M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
- Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of
- Refined Laser Systems — Refined Laser Systems is a dynamic biophotonics company.It specialises in creating innovative laser systems for SRS-microscopy and quantum technology.
R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Austria
Investor stats
- Total investments: 23
- Round size: Seed $614k–$4M; Pre-Seed $429k–$2M; Series A $4.2M–$15M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Silveray — Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
- KetoSwiss — KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases. It develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolicdysfunction (such as Alzheimer's disease). KetoSwiss is headquartered at the Technologie Park Basel, in Basel Switzerland, where it is part of a dynamic scientific and entrepreneurial community composed of world-leading academic research laboratories, flourishing life sciences spin-offs and s world-leading biotech-startup-ecosystem.
- WiseWorks — AI-Powered Communications Intelligence for Financial Institutions
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Austria
Investor stats
- Total investments: 58
- Round size: Seed $1.2M–$6M; Pre-Seed $573k–$964k; Series A $5M–$21M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- basys.ai — Basys.ai automates the process of prior authorization and utilization management to improve costs and timeliness for health plans/payers using an AI-based platform. The proprietary platform automates the process of encoding/digitizing the payer policies using machine learning, thus reducing the piloting timeline by up to 9 months.
- Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
- ALFIE — AI software platform that provides consistent and automated measurements from radiographic images used to assess spinal disorders.
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 52
- Round size: Seed $214k–$964k; Series A $570k–$5.9M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- Circly — Determining tomorrow's needs through sales figures is one of Circly's core competencies, but we go one step further:Circly develops interactive AI construction modules for retailers. Thanks to our modular concept, our users can choose the influencing factors themselves and weight them differently, so that the AI can be adapted to thecompany at any time.With Circly, the supply chain and warehouse utilization can be brought to the next level. We are about to pilot the system and are looking for retailers who are interested in case studies.Description: Machine Learning based Prediction System for the retail sector to forecast the demand in order to avoid food waste, out of stocks and overstock. Other benefits include insights into customer segments and groups, product trends, the possibility of dynamic pricing and marketing!
- Sarcura — Sarcura develops a machine platform for the large scale, GMP manufacturing of personalized cell therapies. Our target is to scale global manufacturing capacity for these life saving, patient specific cancer treatments, cost effective and safe for a all patients. We will transform existing manufacturing paradigms by using semiconductor technologyto bring bioprocess control to cellular level.
- Shopstory — boomerank is a SaaS that helps eCommerce companies grow automatically with help of a powerful AI and the creation of an immense data hub.
venture capital
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Hungary, South Korea, United States
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
- On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
- NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 419
- Round size: Series A $10M–$102M; Series B $23M–$120M; Series C $12M–$108M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Evozyne — We have a new way of thinking about proteins. We've uncovered Nature's hidden rules to build Natural Machines. With our partners, we are changing the world.
- Adela — Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.
- Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 68
- Round size: Seed $250k–$3.8M; Series A $2.5M–$31M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Antaris — The Antaris Open Space platform simplifies the design, simulation, manufacturing and operation of satellites.
- Orakl Oncology — Cultivated with love by the Orakl team.
- Renaissance Fusion — Renaissance Fusion is a high-temperature superconductor and stellarator company.
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Singapore, Ireland
Investor stats
- Total investments: 383
- Round size: Series A $3.5M–$60M; Series B $5.3M–$117M; Series C $11M–$61M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Tausight — Tausight is specifically designed to help Healthcare ensure the confidentiality, integrity, and availability of ePHI.
- Candesant Biomedical — Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis. It offers a technology that is based on the principle that alkali metals in contact with water generate energy. The insight was that when the amounts of metal and water are controlled, the result is targeted delivery of energy exactly at the site of the water. Itsdevice is designed to target and inactivate the most active sweat glands.The company was founded in 2016 and is headquartered in San Francisco, California.
- Crossbow Therapeutics — Crossbow Therapeutics is a seed-stage, stealth-mode oncology startup company. The company develops antibody engineering for intracellular cancer targets.
Life Science Investor funding in Austria at a glance
Stats across 20 deals from 27 investors.
Access all 27 investors in Austria Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 27 investors investing in Austria Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!